Zalevsky Jonathan

Chief R&D Officer at NKTR

Sold, on record
$4.9M
Dollars the filings state
Form 4 sales
37
Latest Nov 17, 2026
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • NKTRNEKTAR THERAPEUTICSChief R&D Officer

Sales by reason

3
Routine
0
Plan not stated
4
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale NKTRNo plan
    Nov 25 2025

    Sold 1,157 shares at $54.28 ($63k)

    Zalevsky Jonathan, Chief R&D Officer

    No 10b5-1 planSold 5.7% of holdings ($1.1M position)18,971 shares left0.2x usual sizeFiling

  2. 2 Form 4 sale NKTRRoutine
    Jan 20 +56 days

    Sold 3,867 shares at $35.67 ($138k)

    Zalevsky Jonathan, Chief R&D Officer

    10b5-1 planSold 15.3% of holdings ($900k position)21,354 shares left0.5x usual sizeFiling

  3. 3 Form 4 sale NKTRNo plan
    Feb 18 +29 days

    Sold 180 shares at $73.00 ($13k)

    Zalevsky Jonathan, Chief R&D Officer

    No 10b5-1 planSold 0.8% of holdings ($1.6M position)21,174 shares left0x usual sizeFiling

  4. 4 Form 4 sale NKTRNo plan
    May 19 +90 days

    Sold 199 shares at $65.51 ($13k)

    Zalevsky Jonathan, Chief R&D Officer

    No 10b5-1 planSold 0.9% of holdings ($1.4M position)20,975 shares left0.1x usual sizeFiling

  5. 5 Form 4 sale NKTRRoutine
    Jun 15 +27 days

    Sold 5,538 shares at $60.71 ($336k)

    Zalevsky Jonathan, Chief R&D Officer

    10b5-1 planSold 26.4% of holdings ($1.3M position)15,437 shares left2x usual sizeFiling

  6. 6 Form 4 sale NKTRRoutine
    Jun 30 +15 days

    Sold 5,681 shares at $70.00 ($398k)

    Zalevsky Jonathan, Chief R&D Officer

    10b5-1 planSold 36.8% of holdings ($1.1M position)9,756 shares left1.5x usual sizeFiling

  7. 7 Form 4 sale NKTRNo plan
    Aug 18 +49 days

    Sold 186 shares at $71.98 ($13k)

    Zalevsky Jonathan, Chief R&D Officer

    No 10b5-1 planSold 1.9% of holdings ($702k position)9,570 shares left0x usual sizeFiling

  8. 8 Form 4 sale NKTRNo plan
    Nov 17 +91 days

    Sold 192 shares at $35.85 ($7k)

    Zalevsky Jonathan, Chief R&D Officer

    No 10b5-1 planSold 2% of holdings ($343k position)9,378 shares left0.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (39)

Form 144 notices and Form 4 sales by Zalevsky Jonathan
Source
Nov 17, 2026NKTRChief R&D OfficerForm 4 sale192$7k2.0%No planSEC
Aug 18, 2026NKTRChief R&D OfficerForm 4 sale186$13k1.9%No planSEC
Jun 30, 2026NKTRChief R&D OfficerForm 4 sale5,681$398k36.8%RoutineSEC
Jun 15, 2026NKTRChief R&D OfficerForm 4 sale5,538$336k26.4%RoutineSEC
May 19, 2026NKTRChief R&D OfficerForm 4 sale199$13k0.9%No planSEC
Feb 18, 2026NKTRChief R&D OfficerForm 4 sale180$13k0.8%No planSEC
Jan 20, 2026NKTRChief R&D OfficerForm 4 sale3,867$138k15.3%RoutineSEC
Nov 25, 2025NKTRChief R&D OfficerForm 4 sale1,157$63k5.7%No planSEC
Sep 4, 2025NKTRChief R&D OfficerForm 4 sale1,721$58k9.0%RoutineSEC
Sep 2, 2025NKTRChief R&D OfficerForm 4 sale485$15k2.5%RoutineSEC
Aug 19, 2025NKTRChief R&D OfficerForm 4 sale725$19k3.6%No planSEC
May 19, 2025NKTRChief R&D OfficerForm 4 sale10,712$7k3.4%No planSEC
Feb 19, 2025NKTRChief R&D OfficerForm 4 sale10,300$10k3.2%No planSEC
Dec 19, 2024NKTRChief R&D OfficerForm 4 sale51,115$48k13.5%UnusualSEC
Dec 19, 2024NKTROfficerForm 144 notice51,115$48kNoticeSEC
Nov 19, 2024NKTRChief R&D OfficerForm 4 sale7,785$8k3.1%No planSEC
Aug 19, 2024NKTRChief R&D OfficerForm 4 sale6,866$9k2.7%No planSEC
May 17, 2024NKTRChief R&D OfficerForm 4 sale7,355$13k2.8%No planSEC
Feb 20, 2024NKTRChief R&D OfficerForm 4 sale9,014$6k3.3%No planSEC
Nov 17, 2023NKTRChief R&D OfficerForm 4 sale9,646$5k3.4%No planSEC
Nov 17, 2023NKTROfficerForm 144 notice9,646$5kNoticeSEC
Aug 16, 2023NKTRChief R&D OfficerForm 4 sale9,703$8k3.3%No planSEC
May 16, 2023NKTRChief R&D OfficerForm 4 sale9,791$7k3.2%No planSEC
Feb 16, 2023NKTRChief R&D OfficerForm 4 sale10,484$31k3.3%Plan not statedSEC
Nov 16, 2022NKTRChief R&D OfficerForm 4 sale13,460$48k4.1%Plan not statedSEC
Aug 18, 2022NKTRChief R&D OfficerForm 4 sale73,716$343k18.4%UnusualSEC
Aug 16, 2022NKTRChief R&D OfficerForm 4 sale10,560$50k2.6%Plan not statedSEC
May 16, 2022NKTRChief R&D OfficerForm 4 sale21,673$86k7.3%Plan not statedSEC
Feb 16, 2022NKTRChief R&D OfficerForm 4 sale10,912$119k3.8%Plan not statedSEC
Nov 16, 2021NKTRChief R&D OfficerForm 4 sale20,869$275k8.3%Plan not statedSEC
Aug 16, 2021NKTRChief R&D OfficerForm 4 sale7,662$106k3.5%Plan not statedSEC
May 17, 2021NKTRChief R&D OfficerForm 4 sale31,111$569k11.7%Plan not statedSEC
Feb 16, 2021NKTRChief R&D OfficerForm 4 sale24,141$540k8.3%Plan not statedSEC
Nov 23, 2020NKTRChief R&D OfficerForm 4 sale16,380$269k6.1%UnusualSEC
Nov 16, 2020NKTRChief R&D OfficerForm 4 sale29,618$501k10.0%UnusualSEC
Aug 17, 2020NKTRChief R&D OfficerForm 4 sale26,200$515k8.1%UnusualSEC
May 18, 2020NKTRChief R&D OfficerForm 4 sale4,558$103k1.4%Plan not statedSEC
Feb 18, 2020NKTRChief R&D OfficerForm 4 sale4,774$107k1.4%Plan not statedSEC
Nov 18, 2019NKTRChief R&D OfficerForm 4 sale3,960$71k1.3%Plan not statedSEC